تحميل...

Complement enhances in vitro neutralizing potency of antibodies to human cytomegalovirus glycoprotein B (gB) and immune sera induced by gB/MF59 vaccination

Human cytomegalovirus (HCMV) is the leading cause of in utero viral infection in the United States. Since congenital HCMV infection can lead to birth defects in newborns, developing a prophylactic vaccine is a high priority. One of the early experimental vaccines, composed of a recombinant glycoprot...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	NPJ Vaccines
المؤلفون الرئيسيون:	Li, Fengsheng, Freed, Daniel C., Tang, Aimin, Rustandi, Richard R., Troutman, Matthew C., Espeseth, Amy S., Zhang, Ningyan, An, Zhiqiang, McVoy, Michael, Zhu, Hua, Ha, Sha, Wang, Dai, Adler, Stuart P., Fu, Tong-Ming
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	Nature Publishing Group UK 2017
الموضوعات:	Article
الوصول للمادة أونلاين:	https://ncbi.nlm.nih.gov/pmc/articles/PMC5730571/ https://ncbi.nlm.nih.gov/pubmed/29263890 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41541-017-0038-0
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

Complement enhances in vitro neutralizing potency of antibodies to human cytomegalovirus glycoprotein B (gB) and immune sera induced by gB/MF59 vaccination

مواد مشابهة